Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Regeneron Pharmaceuticals, Inc. (REGN) since 2005 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Regeneron Pharmaceuticals, Inc.. (See page 1 of this report.) Table 2 shows the detailed insider transactions. This company's CIK number is 872589.
Total stock buying since 2005: $2,475,753,844.
Total stock sales since 2005: $14,586,084,237.
Total stock option exercises since 2005: $1,313,104,322.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2024 | 0 | $0 | 210,364 | $207,522,474 | 616,322 | $254,112,622 |
| 2023 | 0 | $0 | 95,808 | $78,349,729 | 273,334 | $75,352,970 |
| 2022 | 0 | $0 | 209,705 | $142,182,035 | 469,330 | $145,352,340 |
| 2021 | 0 | $0 | 563,365 | $351,623,746 | 2,003,096 | $333,732,044 |
| 2020 | 0 | $0 | 24,311,062 | $12,445,396,750 | 1,955,372 | $164,839,706 |
| 2019 | 0 | $0 | 416,206 | $143,310,975 | 917,671 | $23,311,139 |
| 2018 | 0 | $0 | 427,003 | $148,810,340 | 927,576 | $18,552,974 |
| 2017 | 462,141 | $212,021,764 | 137,384 | $65,407,790 | 900,886 | $27,301,249 |
| 2016 | 148,669 | $62,482,433 | 20,663 | $8,394,544 | 774,368 | $17,691,794 |
| 2015 | 260,466 | $131,463,987 | 420,930 | $219,457,542 | 678,280 | $37,168,578 |
| 2014 | 6,498,829 | $2,040,580,495 | 592,551 | $211,494,397 | 1,689,378 | $74,072,416 |
| 2013 | 0 | $0 | 979,452 | $254,768,275 | 1,464,593 | $33,265,521 |
| 2012 | 0 | $0 | 1,215,019 | $159,380,088 | 2,319,093 | $46,475,631 |
| 2011 | 0 | $0 | 729,476 | $37,856,945 | 1,678,597 | $36,895,258 |
| 2010 | 1,034,901 | $28,971,078 | 317,918 | $9,118,977 | 332,278 | $5,014,862 |
| 2009 | 12,500 | $234,087 | 114,271 | $2,249,950 | 651,002 | $5,760,483 |
| 2008 | 0 | $0 | 156,479 | $3,272,738 | 500,195 | $4,022,051 |
| 2007 | 0 | $0 | 224,867 | $5,157,435 | 316,441 | $3,033,949 |
| 2006 | 0 | $0 | 443,650 | $8,648,660 | 580,125 | $5,427,485 |
| 2005 | 0 | $0 | 7,562,667 | $83,680,847 | 135,000 | $1,721,250 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2008-12-16 | Yancopoulos George (EVP, CSO, & Pres Regn Res Labs) | Sale | 26,991 | 16.40 | 442,652 |
| 2008-12-16 | Yancopoulos George (EVP, CSO, & Pres Regn Res Labs) | Option Ex | 100,000 | 7.41 | 741,000 |
| 2008-12-15 | Goldberg Murray A (SVP F&A, CFO, Treas, & Ast Sec) | Option Ex | 1,700 | 7.41 | 12,597 |
| 2008-10-01 | Mccorkle Douglas S (VP, Controller and Asst. Treas) | Sale | 32,664 | 21.64 | 707,898 |
| 2008-10-01 | Mccorkle Douglas S (VP, Controller and Asst. Treas) | Option Ex | 32,664 | 11.25 | 371,304 |
| 2008-10-01 | Goldstein Joseph L (Director) | Sale | 500 | 22.32 | 11,160 |
| 2008-09-30 | Stahl Neil (SVP, Research & Devel Sciences) | Sale | 10,317 | 21.68 | 223,693 |
| 2008-09-29 | Stahl Neil (SVP, Research & Devel Sciences) | Option Ex | 25,000 | 8.77 | 219,250 |
| 2008-09-29 | Schleifer Leonard S (Chief Exec Officer & President) | Option Ex | 73,010 | 7.41 | 541,004 |
| 2008-09-22 | Roberts William (VP, Regul Devel & Med Safety) | Sale | 9,692 | 22.84 | 221,365 |
| 2008-09-19 | Kolinski Stuart (SVP, Gen Counsel & Secretary) | Sale | 9,992 | 23.61 | 235,961 |
| 2008-09-19 | Kolinski Stuart (SVP, Gen Counsel & Secretary) | Option Ex | 9,992 | 8.50 | 84,932 |
| 2008-09-16 | Roberts William (VP, Regul Devel & Med Safety) | Option Ex | 25,000 | 8.77 | 219,250 |
| 2008-09-09 | Brown Michael S (Director) | Option Ex | 5,000 | 7.66 | 38,300 |
| 2008-08-20 | Roberts William (VP, Regul Devel & Med Safety) | Option Ex | 34,840 | 6.50 | 226,460 |
| 2008-05-30 | Shooter Eric M (Director) | Sale | 15,000 | 19.84 | 297,525 |
| 2008-05-30 | Shooter Eric M (Director) | Option Ex | 15,000 | 9.17 | 137,550 |
| 2008-02-27 | Vagelos P Roy (Director) | Option Ex | 6,666 | 7.91 | 52,708 |
| 2008-02-15 | Baker Charles A (Director) | Sale | 10,000 | 18.85 | 188,460 |
| 2008-02-15 | Baker Charles A (Director) | Option Ex | 10,000 | 7.91 | 79,070 |
| 2008-01-22 | Goldstein Joseph L (Director) | Sale | 5,000 | 25.00 | 125,000 |
| 2008-01-22 | Goldstein Joseph L (Director) | Option Ex | 5,000 | 7.66 | 38,300 |
| 2008-01-22 | Brown Michael S (Director) | Sale | 9,800 | 25.00 | 245,000 |
| 2008-01-17 | Brown Michael S (Director) | Sale | 200 | 25.00 | 5,000 |
| 2007-12-20 | Schleifer Leonard S (Chief Exec Officer & President) | Option Ex | 37,370 | 8.62 | 322,316 |
| 2007-11-06 | Brown Michael S (Director) | Sale | 6,108 | 19.65 | 119,997 |
| 2007-11-05 | Goldstein Joseph L (Director) | Sale | 5,000 | 20.62 | 102,803 |
| 2007-11-05 | Goldstein Joseph L (Director) | Option Ex | 5,000 | 7.66 | 38,300 |
| 2007-11-05 | Brown Michael S (Director) | Sale | 10,000 | 20.63 | 205,067 |
| 2007-11-05 | Brown Michael S (Director) | Option Ex | 10,000 | 7.91 | 79,100 |
| 2007-11-02 | Mccorkle Douglas S (VP, Controller and Asst. Treas) | Sale | 6,209 | 21.00 | 130,407 |
| 2007-11-02 | Mccorkle Douglas S (VP, Controller and Asst. Treas) | Option Ex | 6,209 | 8.75 | 54,310 |
| 2007-10-02 | Shooter Eric M (Director) | Sale | 20,000 | 18.33 | 366,680 |
| 2007-10-02 | Shooter Eric M (Director) | Option Ex | 20,000 | 7.66 | 153,200 |
| 2007-04-26 | Goldberg Murray A (SVP Fin & Admin, CFO, & Treas) | Sale | 8,931 | 27.16 | 242,583 |
| 2007-04-25 | Goldberg Murray A (SVP Fin & Admin, CFO, & Treas) | Option Ex | 20,189 | 9.13 | 184,325 |
| 2007-04-23 | Stahl Neil (SVP, Research & Devel Sciences) | Sale | 10,988 | 25.55 | 280,776 |
| 2007-04-23 | Goldberg Murray A (SVP Fin & Admin, CFO, & Treas) | Sale | 4,835 | 25.56 | 123,577 |
| 2007-04-20 | Stahl Neil (SVP, Research & Devel Sciences) | Option Ex | 25,000 | 8.77 | 219,250 |
| 2007-04-20 | Goldberg Murray A (SVP Fin & Admin, CFO, & Treas) | Option Ex | 11,000 | 8.77 | 96,470 |
| 2007-04-16 | Yancopoulos George (EVP, CSO, & Pres Regn Res Labs) | Sale | 31,283 | 24.79 | 769,008 |
| 2007-04-13 | Yancopoulos George (EVP, CSO, & Pres Regn Res Labs) | Option Ex | 90,444 | 10.56 | 955,359 |
| 2007-04-13 | Rupp Randall (SVP, Manufuring Operations) | Sale | 31,250 | 24.94 | 779,406 |
| 2007-04-13 | Rupp Randall (SVP, Manufuring Operations) | Option Ex | 31,250 | 11.95 | 373,343 |
| 2007-04-13 | Goldberg Murray A (SVP Fin & Admin, CFO, & Treas) | Sale | 7,624 | 24.84 | 189,342 |
| 2007-04-13 | Goldberg Murray A (SVP Fin & Admin, CFO, & Treas) | Option Ex | 7,624 | 8.62 | 65,757 |
| 2007-04-09 | Yancopoulos George (EVP, CSO, & Pres Regn Res Labs) | Sale | 9,556 | 23.83 | 227,738 |
| 2007-04-09 | Yancopoulos George (EVP, CSO, & Pres Regn Res Labs) | Option Ex | 9,556 | 10.56 | 100,940 |
| 2007-02-26 | Gilman Alfred G (Director) | Sale | 10,000 | 21.49 | 214,512 |
| 2007-02-26 | Gilman Alfred G (Director) | Option Ex | 10,000 | 9.88 | 98,800 |
| 2007-01-30 | Vagelos P Roy (Director) | Option Ex | 6,666 | 9.88 | 65,826 |
| 2006-11-21 | Shooter Eric M (Director) | Sale | 10,000 | 22.85 | 228,480 |
| 2006-11-21 | Shooter Eric M (Director) | Option Ex | 10,000 | 9.88 | 98,750 |
| 2006-11-20 | Goldberg Murray A (SVP Fin & Admin, CFO, & Treas) | Sale | 1,200 | 24.76 | 29,712 |
| 2006-11-20 | Goldberg Murray A (SVP Fin & Admin, CFO, & Treas) | Option Ex | 6,200 | 8.32 | 51,590 |
| 2006-11-08 | Goldberg Murray A (SVP Fin & Admin, CFO, & Treas) | Sale | 4,065 | 23.56 | 95,924 |
| 2006-11-07 | Goldberg Murray A (SVP Fin & Admin, CFO, & Treas) | Sale | 8,797 | 23.32 | 205,172 |
| 2006-11-07 | Goldberg Murray A (SVP Fin & Admin, CFO, & Treas) | Option Ex | 10,176 | 8.67 | 88,256 |
| 2006-11-07 | Schleifer Leonard S (Chief Exec Officer & President) | Sale | 53,986 | 23.11 | 1,247,886 |
| 2006-11-06 | Goldberg Murray A (SVP Fin & Admin, CFO, & Treas) | Sale | 10,000 | 22.75 | 227,500 |
| 2006-11-06 | Goldberg Murray A (SVP Fin & Admin, CFO, & Treas) | Option Ex | 30,899 | 8.80 | 272,003 |
| 2006-11-06 | Schleifer Leonard S (Chief Exec Officer & President) | Option Ex | 150,000 | 9.06 | 1,359,300 |
| 2006-11-06 | Brown Michael S (Director) | Sale | 5,000 | 23.00 | 115,000 |
| 2006-11-01 | Stahl Neil (SVP, Therap & Clin Prog Dev) | Sale | 5,760 | 20.00 | 115,200 |
| 2006-10-31 | Stahl Neil (SVP, Therap & Clin Prog Dev) | Sale | 41,689 | 20.07 | 836,531 |
| 2006-10-31 | Stahl Neil (SVP, Therap & Clin Prog Dev) | Option Ex | 60,000 | 10.49 | 629,220 |
| 2006-10-31 | Rupp Randall (SVP, Manufuring Operations) | Sale | 143,750 | 20.04 | 2,881,181 |
| 2006-10-31 | Rupp Randall (SVP, Manufuring Operations) | Option Ex | 143,750 | 9.05 | 1,300,506 |
| 2006-10-31 | Brown Michael S (Director) | Sale | 4,000 | 20.00 | 80,000 |
| 2006-10-19 | Brown Michael S (Director) | Sale | 2,000 | 19.50 | 39,000 |
| 2006-10-18 | Brown Michael S (Director) | Sale | 2,469 | 18.00 | 44,442 |
| 2006-10-17 | Schleifer Leonard S (Chief Exec Officer & President) | Sale | 30,000 | 18.02 | 540,750 |
| 2006-10-17 | Brown Michael S (Director) | Option Ex | 10,000 | 9.88 | 98,750 |
| 2006-09-13 | Schleifer Leonard S (Chief Exec Officer & President) | Sale | 14,100 | 16.55 | 233,369 |
| 2006-09-01 | Rupp Randall (SVP, Manufuring Operations) | Sale | 23,461 | 15.71 | 368,689 |
| 2006-09-01 | Rupp Randall (SVP, Manufuring Operations) | Option Ex | 20,000 | 9.50 | 190,000 |
| 2006-08-17 | Kolinski Stuart (VP, Gen Counsel & Secretary) | Sale | 2,000 | 15.00 | 30,000 |
| 2006-03-16 | Brown Michael S (Director) | Sale | 1,721 | 17.00 | 29,257 |
| 2006-03-14 | Brown Michael S (Director) | Sale | 1,537 | 17.00 | 26,129 |
| 2006-03-10 | Shooter Eric M (Director) | Sale | 5,283 | 17.00 | 89,800 |
| 2006-03-09 | Shooter Eric M (Director) | Option Ex | 10,000 | 7.91 | 79,070 |
| 2006-03-07 | Schleifer Leonard S (Chief Exec Officer & President) | Sale | 802 | 18.00 | 14,436 |
| 2006-03-06 | Schleifer Leonard S (Chief Exec Officer & President) | Sale | 1,400 | 18.00 | 25,200 |
| 2006-02-06 | Stahl Neil (Biomol Sci) | Sale | 8,599 | 16.11 | 138,572 |
| 2006-02-03 | Stahl Neil (Biomol Sci) | Sale | 16,000 | 15.86 | 253,760 |
| 2006-02-03 | Stahl Neil (Biomol Sci) | Option Ex | 40,000 | 7.41 | 296,400 |
| 2006-02-01 | Baker Charles A (Director) | Sale | 10,000 | 15.35 | 153,520 |
| 2006-02-01 | Baker Charles A (Director) | Option Ex | 10,000 | 12.00 | 120,000 |
| 2006-01-09 | Yancopoulos George (EVP, CSO, & Pres Reg) | Sale | 900 | 17.24 | 15,512 |
| 2006-01-09 | Stahl Neil (Biomol Sci) | Sale | 1,744 | 17.24 | 30,059 |
| 2006-01-09 | Rupp Randall (SVP, Manufuring Ope) | Sale | 1,682 | 16.88 | 28,392 |
| 2006-01-09 | Kolinski Stuart (Secretary) | Sale | 1,621 | 17.24 | 27,939 |
| 2006-01-09 | Goldberg Murray A (Treas) | Sale | 2,177 | 17.24 | 37,522 |
| 2006-01-09 | Sing George L (Director) | Option Ex | 40,000 | 9.36 | 374,440 |
| 2006-01-09 | Brown Michael S (Director) | Option Ex | 10,000 | 12.00 | 120,000 |
| 2006-01-06 | Gilman Alfred G (Director) | Sale | 10,000 | 16.26 | 161,386 |
| 2006-01-06 | Gilman Alfred G (Director) | Option Ex | 10,000 | 12.00 | 120,000 |
| 2006-01-05 | Rupp Randall (SVP, Manufuring Ope) | Sale | 4,000 | 15.80 | 63,200 |
| 2006-01-04 | Shooter Eric M (Director) | Sale | 2,406 | 15.89 | 38,221 |
| 2006-01-03 | Shooter Eric M (Director) | Option Ex | 10,000 | 12.00 | 120,000 |
| 2005-12-27 | Yancopoulos George (EVP, CSO, & Pres Reg) | Sale | 5,500 | 14.87 | 81,801 |
| 2005-12-27 | Yancopoulos George (EVP, CSO, & Pres Reg) | Option Ex | 25,000 | 12.75 | 318,750 |
| 2005-12-27 | Kolinski Stuart (Secretary) | Sale | 3,000 | 15.00 | 45,000 |
| 2005-12-27 | Goldberg Murray A (Treas) | Sale | 492 | 14.94 | 7,350 |
| 2005-12-27 | Schleifer Leonard S (Chief Exec Officer &) | Option Ex | 80,000 | 12.75 | 1,020,000 |
| 2005-12-23 | Goldberg Murray A (Treas) | Sale | 12,150 | 13.08 | 158,958 |
| 2005-12-23 | Goldberg Murray A (Treas) | Option Ex | 30,000 | 12.75 | 382,500 |
| 2005-11-08 | Novartis Pharma Ag (10% Owner) | Sale | 7,527,050 | 11.06 | 83,249,173 |
| 2005-08-05 | Stahl Neil (Biomol Sci) | Sale | 10,677 | 9.50 | 101,399 |
| 2005-07-20 | Goldberg Murray A (Treas) | Sale | 2,177 | 10.00 | 21,770 |
| 2005-07-11 | Kolinski Stuart (Secretary) | Sale | 1,621 | 9.50 | 15,396 |
Insider trading activities including stock purchases, stock sales, and option exercises of REGN listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Regeneron Pharmaceuticals, Inc. (symbol REGN, CIK number 872589) see the Securities and Exchange Commission (SEC) website.